BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7913670)

  • 1. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.
    Volm M; van Kaick G; Mattern J
    Clin Exp Metastasis; 1994 Jul; 12(4):329-34. PubMed ID: 7913670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases.
    Volm M; Drings P; Wodrich W; van Kaick G
    Clin Exp Metastasis; 1993 Jul; 11(4):325-9. PubMed ID: 8100491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers.
    Wodrich W; Volm M
    Carcinogenesis; 1993 Jun; 14(6):1121-4. PubMed ID: 8389672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
    Volm M; Drings P; Wodrich W
    J Cancer Res Clin Oncol; 1993; 119(9):507-10. PubMed ID: 8100821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cadmium on hepatocellular DNA damage, proto-oncogene expression and apoptosis in rats.
    Yu RA; He LF; Chen XM
    Biomed Environ Sci; 2007 Apr; 20(2):146-53. PubMed ID: 17624190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus.
    Zheng X; Hendry WJ
    Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis.
    Li X; Shi ZM; Feng P; Wen ZY; Wang XJ
    World J Gastroenterol; 2007 Aug; 13(31):4192-8. PubMed ID: 17696247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
    Volm M; Rittgen W; Drings P
    Br J Cancer; 1998 Feb; 77(4):663-9. PubMed ID: 9484827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
    Li H; Xie P; Li G; Hao L; Xiong Q
    Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
    Yokoyama Y; Sagara M; Sato S; Saito Y
    Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
    J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy.
    Miura K; Suzuki S; Tanita J; Shinkawa H; Satoh K; Tsuchida S
    Jpn J Cancer Res; 1997 Feb; 88(2):143-51. PubMed ID: 9119742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene expression in carotid body tumors.
    Wang DG; Barros D'Sa AA; Johnston CF; Buchanan KD
    Cancer; 1996 Jun; 77(12):2581-7. PubMed ID: 8640709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas.
    Volm M; Koomagi R; Kaufmann M; Mattern J; Stammler G
    Clin Exp Metastasis; 1996 May; 14(3):209-14. PubMed ID: 8674274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
    Riva C; Lavieille JP; Reyt E; Brambilla E; Lunardi J; Brambilla C
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):384-91. PubMed ID: 8746269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.